Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/446
Full metadata record
DC FieldValueLanguage
dc.contributor.authorExternal author(s) only
dc.date.accessioned2020-05-01T16:24:44Z
dc.date.available2020-05-01T16:24:44Z
dc.date.issued2020-04
dc.identifier.citationKile Green, Sara Graziadio, Philip Turner, Thomas Fanshawe, Joy Allen. Molecular and antibody point-of-care tests to support the screening, diagnosis and monitoring of COVID-19 . www.cebm.net/oxford-covid-19/en
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/446
dc.descriptionSupported by NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative, Oxford Health NHS Foundation Trusten
dc.description.abstractMoving diagnostic testing for COVID-19 from laboratory settings to the point of care is potentially transformative in the rate and quantity of testing that could be performed. Eleven diagnostic tests that are potentially suitable for testing for COVID-19 at the point-of-care are described: six molecular tests, and five antibody-based tests. Some devices show high diagnostic accuracy during controlled testing, but performance data from clinical settings, and a clear understanding of the optimal population and role for these tests in the care pathway, are currently lacking.en
dc.description.sponsorshipSupported by the NIHRen
dc.description.urihttps://www.cebm.net/wp-content/uploads/2020/04/POCT-Covid19.pdfen
dc.language.isoenen
dc.subjectCOVID-19en
dc.subjectPoint of Care Testingen
dc.titleMolecular and antibody point-of-care tests to support the screening, diagnosis and monitoring of COVID-19en
dc.typeArticleen
Appears in Collections:Communicable Diseases

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.